Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Curacyte AG sells subsidiary for €14.5 million
September 2008
SHARING OPTIONS:

MUNICH, Germany—Curacyte AG announced recently that it sold its wholly owned subsidiary, Curacyte Discovery GmbH based in Leipzig, Germany, to The Medicines Co. for €14.5 million. Curacyte Discovery is engaged in the development of synthetic serine protease inhibitors in the area of hemostasis and anti-coagulation. Its rationally-designed lead development candidate, CU-2010, is being developed for preventing surgical blood loss. It is scheduled to enter Phase I clinical development by the end of 2008. DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.